Pharming Group NV (PHAR)
11.96
+0.50
(+4.36%)
USD |
NASDAQ |
Aug 25, 16:00
11.96
0.00 (0.00%)
After-Hours: 18:56
Pharming Group Price to Book Value : 3.293 for Aug. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 3.156 |
| August 21, 2026 | 3.263 |
| August 20, 2026 | 3.216 |
| August 19, 2026 | 3.263 |
| August 18, 2026 | 3.280 |
| August 17, 2026 | 3.247 |
| August 14, 2026 | 3.227 |
| August 13, 2026 | 3.401 |
| August 12, 2026 | 3.258 |
| August 11, 2026 | 3.368 |
| August 10, 2026 | 3.125 |
| August 07, 2026 | 3.015 |
| August 06, 2026 | 2.988 |
| August 05, 2026 | 2.940 |
| August 04, 2026 | 2.825 |
| August 03, 2026 | 2.704 |
| July 31, 2026 | 2.776 |
| July 30, 2026 | 2.960 |
| July 29, 2026 | 3.307 |
| July 28, 2026 | 3.541 |
| July 27, 2026 | 3.583 |
| July 24, 2026 | 3.474 |
| July 23, 2026 | 3.627 |
| July 22, 2026 | 3.569 |
| July 21, 2026 | 3.614 |
| Date | Value |
|---|---|
| July 20, 2026 | 3.610 |
| July 17, 2026 | 3.709 |
| July 16, 2026 | 3.660 |
| July 15, 2026 | 3.690 |
| July 14, 2026 | 3.694 |
| July 13, 2026 | 3.792 |
| July 10, 2026 | 3.817 |
| July 09, 2026 | 3.866 |
| July 08, 2026 | 3.938 |
| July 07, 2026 | 3.982 |
| July 06, 2026 | 3.940 |
| July 02, 2026 | 3.792 |
| July 01, 2026 | 3.760 |
| June 30, 2026 | 3.825 |
| June 29, 2026 | 3.494 |
| June 26, 2026 | 3.479 |
| June 25, 2026 | 3.461 |
| June 24, 2026 | 3.385 |
| June 23, 2026 | 3.356 |
| June 22, 2026 | 3.315 |
| June 18, 2026 | 3.357 |
| June 17, 2026 | 3.299 |
| June 16, 2026 | 3.262 |
| June 15, 2026 | 3.342 |
| June 12, 2026 | 3.339 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ProQR Therapeutics NV | 3.673 |
| NewAmsterdam Pharma Co. NV | 5.090 |
| argenx SE | -- |
| DBV Technologies SA | 4.242 |
| ACADIA Pharmaceuticals, Inc. | 4.029 |
Price to Book Value Related Metrics
| PE Ratio | 96.22 |
| PS Ratio | 2.404 |
| Price to Free Cash Flow | 34.26 |
| Price | 11.96 |
| Earnings Yield | 1.04% |
| Market Cap | 846.51M |
| Operating PE Ratio | 39.39 |
| Normalized PE Ratio | 53.68 |